Use of thrombolytic agents for ST-elevation myocardial infarction care in India: An expert consensus

Use of thrombolytic agents for ST-elevation myocardial infarction care in India: An expert consensus

In India, ST-elevation myocardial infarction (STEMI) is the predominant form of acute coronary syndrome. It is estimated to affect approximately 30 million people in India. The mainstay treatment approach for STEMI management is primary percutaneous coronary intervention (PCI) within 90 min after th...

Full description

Bibliographic Details
Main Authors: Arun Chopra, Suresh V Patted, Mukesh Parikh, Rajeev Agarwal, K Jaishankar, Nitin Modi
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2021-01-01
Series:Journal of the Practice of Cardiovascular Sciences
Subjects:
percutaneous coronary intervention
pharmaco-invasive
reperfusion
reteplase
st-elevation myocardial infarction
streptokinase
tenecteplase
thrombolysis
Online Access:http://www.j-pcs.org/article.asp?issn=2395-5414;year=2021;volume=7;issue=3;spage=182;epage=189;aulast=Chopra

Internet

http://www.j-pcs.org/article.asp?issn=2395-5414;year=2021;volume=7;issue=3;spage=182;epage=189;aulast=Chopra

Similar Items